BSc, MBBS, MRCP, FRCR, FRCP, CCST
I have been a Consultant Clinical Oncologist in Reading since 2001, specialising in the treatment of colorectal, head and neck and non melanomatous skin cancers.
I graduated from King's College London and subsequently worked in Reading at the Royal Berkshire Hospital as an SHO. I then moved to the Wessex rotation where I specialised in Oncology.
I have been the Clinical Director of the Berkshire Cancer Centre since 2021; and am also the RO for the Royal Berkshire Hospital, a position I hold as part of my role as Associate Medical Director for Professional Standards.
I have taken part in national bowel cancer clinical trials such as the SCOT trial, looking at the length of chemotherapy needed in bowel cancer. I have also taken part in the COIN trial looking at the best duration of palliative chemotherapy for patients with bowel cancer and the Add Aspirin trial, which is currently ongoing. We have also been part of other trials such as Plato and Pathos.
Some of the principal treatments carried out by Dr Alice Freebairn at Spire include:
Other treatments
COVID-19 testing or antibody tests are not available as a standalone service at Spire Dunedin Hospital.
BSc. / King's College London / 1992
Bachelor of Medicine
Member of the Royal College of Physicians
Fellow of the Royal College of Radiologists
Consultant Clinical Oncologist, Royal Berkshire Hospital, Reading, Berkshire
Telephone | 0118 955 3531 |
Private secretary | Donna Gardner |
Private secretary fax | 0118 955 3519 |
Private secretary email | donna.gardner@spirehealthcare.com |